A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

Alcon Research

Overview

To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Glaucoma, Open-Angle Ocular Hypertension

Interventions

Travoprost (0.004%)DRUG

Latanoprost (0.005%)/Timolol (0.5%)DRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Patients of any race and either sex with open-angle glaucoma (with or without pigment dispersion or pseudoexfoliation component) or ocular hypertension.

Locations (1)

Europe

Fort Worth, Texas, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.